Computational analysis of a previously identified antigenic mimotope recognized by fingerprinting human autoantibodies from ovarian cancer patients [3] with more than two decades of accumulated biomedical data supports MMP14 and other MMPs as potential targets for discovery and development of translational theranostics. Here, MMP14 is linked to ovarian cancer.